Skip to content
Screener

Jade Biosciences JBIO Price / book

Price / book at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
6.2×-0.5×
Climb Global Solutions, Inc. logo
Climb Global Solutions, Inc.CLMB
3.1×-2.2×
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
27.8×-20.7×
Vera Therapeutics logo
Vera TherapeuticsVERA
5.7×+2.9×
Vor Biopharma logo
Vor BiopharmaVOR
1.4×0.0×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
125.1×+108×

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K—
Free cash flow-$33.7M—

Valuation

See full
Market cap$1.35B+436%
Enterprise value$1.3B+3,925%

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity0×—
Current ratio14.3×-17.7×

Where this comes from

Calculated from Jade Biosciences’s reported figures.

market cap/total stockholders equity=2.3×

Based on the most recent quarter.

The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:27 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212088

FAQ

What is Jade Biosciences's price / book?
Jade Biosciences (JBIO) reported price / book of 2.3× in Q1 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Jade Biosciences's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude